Neuronetics logo

Neuronetics share price today

(STIM)

Neuronetics share price is $1.57 & ₹134.72 as on 7 Jan 2025, 2.30 'hrs' IST

$1.57

0.08

(5.37%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Neuronetics share price in Dollar and Rupees. Guide to invest in Neuronetics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Neuronetics, along with analyst recommendations, forecasts, and comprehensive financials.

Neuronetics share price movements

  • Today's Low: $1.49
    Today's High: $1.58

    Day's Volatility :5.68%

  • 52 Weeks Low: $0.52
    52 Weeks High: $5.07

    52 Weeks Volatility :89.74%

Neuronetics Returns

PeriodNeuronetics IncSector (Health Care)Index (Russel 2000)
3 Months
73.26%
-8.4%
0.0%
6 Months
-18.13%
-3.8%
0.0%
1 Year
-46.79%
-0.1%
0.0%
3 Years
-65.51%
2.9%
-19.8%

Neuronetics Key Statistics

in dollars & INR

Previous Close
$1.49
Open
$1.49
Today's High
$1.5797
Today's Low
$1.49
Market Capitalization
$89.6M
Today's Volume
$172.9K
52 Week High
$5.0699
52 Week Low
$0.52
Revenue TTM
$72.1M
EBITDA
$-24.6M
Earnings Per Share (EPS)
$-1.22
Profit Margin
-45.06%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-100.13%

How to invest in Neuronetics from India?

It is very easy for Indian residents to invest directly in Neuronetics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neuronetics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neuronetics or STIM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neuronetics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neuronetics shares which would translate to 0.547 fractional shares of Neuronetics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Neuronetics, in just a few clicks!

Returns in Neuronetics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neuronetics investment value today

Current value as on today

₹59,294

Returns

₹40,706

(-40.71%)

Returns from Neuronetics Stock

₹43,929 (-43.93%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Neuronetics

-69%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Neuronetics on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -69% less investors are searching Neuronetics in the last 30 days versus the previous period.

Global Institutional Holdings in Neuronetics

  • Kent Lake Capital LLC

    5.73%

  • Cannell Capital LLC

    4.33%

  • Vanguard Group Inc

    4.28%

  • Masters Capital Management LLC

    3.95%

  • Balyasny Asset Management LLC

    3.77%

  • Renaissance Technologies Corp

    1.92%

Analyst Recommendation on Neuronetics

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Neuronetics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Neuronetics

What analysts predicted

Upside of 69.85%

Current:

$1.57

Target:

$2.67

Insights on Neuronetics

  • Price Movement

    In the last 1 month, STIM stock has moved up by 17.3%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 16.45M → 18.53M (in $), with an average increase of 11.2% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -5.37M → -13.34M (in $), with an average decrease of 35.7% per quarter
  • STIM vs A (1 yr)

    In the last 1 year, Agilent Technologies Inc. has given 3.9% return, outperforming this stock by 54.1%
  • STIM vs A (3 yr)

    In the last 3 years, Neuronetics Inc has experienced a drawdown of -61.8%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 52.8%
  • Price to Sales

    ForSTIM every $1 of sales, investors are willing to pay $0.6, whereas for Agilent Technologies Inc., the investors are paying $6.1 for every $1 of sales.

Neuronetics Financials in INR & Dollars

FY18Y/Y Change
Revenue
$52.8M
↑ 30.53%
Net Income
$-24.1M
↑ 50.05%
Net Profit Margin
-45.66%
↓ 5.94%
FY19Y/Y Change
Revenue
$62.7M
↑ 18.72%
Net Income
$-34.3M
↑ 42.34%
Net Profit Margin
-54.74%
↓ 9.08%
FY20Y/Y Change
Revenue
$49.2M
↓ 21.41%
Net Income
$-32.3M
↓ 5.9%
Net Profit Margin
-65.55%
↓ 10.81%
FY21Y/Y Change
Revenue
$55.3M
↑ 12.32%
Net Income
$-35.6M
↑ 10.3%
Net Profit Margin
-64.37%
↑ 1.18%
FY22Y/Y Change
Revenue
$65.2M
↑ 17.89%
Net Income
$-39.2M
↑ 10.13%
Net Profit Margin
-60.13%
↑ 4.24%
FY23Y/Y Change
Revenue
$71.3M
↑ 9.42%
Net Income
$-30.2M
↓ 23.0%
Net Profit Margin
-42.31%
↑ 17.82%
Q2 FY23Q/Q Change
Revenue
$17.6M
↑ 13.32%
Net Income
$-4.9M
↓ 55.98%
Net Profit Margin
-27.83%
↑ 43.81%
Q3 FY23Q/Q Change
Revenue
$17.9M
↑ 1.56%
Net Income
$-9.4M
↑ 91.61%
Net Profit Margin
-52.51%
↓ 24.68%
Q4 FY23Q/Q Change
Revenue
$20.3M
↑ 13.59%
Net Income
$-5.4M
↓ 42.74%
Net Profit Margin
-26.47%
↑ 26.04%
Q1 FY24Q/Q Change
Revenue
$17.4M
↓ 14.26%
Net Income
$-7.9M
↑ 46.42%
Net Profit Margin
-45.2%
↓ 18.73%
Q2 FY24Q/Q Change
Revenue
$16.5M
↓ 5.55%
Net Income
$-9.8M
↑ 24.88%
Net Profit Margin
-59.77%
↓ 14.57%
Q3 FY24Q/Q Change
Revenue
$18.5M
↑ 12.64%
Net Income
$-13.3M
↑ 35.69%
Net Profit Margin
-72.0%
↓ 12.23%
FY18Y/Y Change
Profit
$40.3M
↑ 30.93%
FY19Y/Y Change
Profit
$47.3M
↑ 17.2%
FY20Y/Y Change
Profit
$37.7M
↓ 20.26%
FY21Y/Y Change
Profit
$43.7M
↑ 15.84%
FY22Y/Y Change
Profit
$49.7M
↑ 13.89%
FY23Y/Y Change
Profit
$51.7M
↑ 3.99%
Q2 FY23Q/Q Change
Profit
$12.8M
↑ 12.09%
Q3 FY23Q/Q Change
Profit
$11.8M
↓ 7.91%
Q4 FY23Q/Q Change
Profit
$15.3M
↑ 29.79%
Q1 FY24Q/Q Change
Profit
$12.5M
↓ 17.95%
Q2 FY24Q/Q Change
Profit
$12.2M
↓ 2.79%
Q3 FY24Q/Q Change
Profit
$14.0M
↑ 14.96%
FY18Y/Y Change
Operating Cash Flow
$-20.6M
↑ 84.77%
Investing Cash Flow
$-1.0M
↑ 70.2%
Financing Cash Flow
$97.0M
↑ 306.95%
FY19Y/Y Change
Operating Cash Flow
$-30.5M
↑ 48.04%
Investing Cash Flow
$-813.0K
↓ 19.58%
Financing Cash Flow
$2.4M
↓ 97.51%
FY20Y/Y Change
Operating Cash Flow
$-28.4M
↓ 6.86%
Investing Cash Flow
$-730.0K
↓ 10.21%
Financing Cash Flow
$2.4M
↓ 2.11%
FY21Y/Y Change
Operating Cash Flow
$-28.0M
↓ 1.43%
Investing Cash Flow
$-9.8M
↑ 1247.81%
Financing Cash Flow
$83.0M
↑ 3403.84%
FY22Y/Y Change
Operating Cash Flow
$-30.7M
↑ 9.85%
Investing Cash Flow
$6.7M
↓ 168.41%
Financing Cash Flow
$207.0K
↓ 99.75%
Q2 FY23Q/Q Change
Operating Cash Flow
$-15.0M
↑ 66.71%
Investing Cash Flow
$-642.0K
↑ 250.82%
Financing Cash Flow
$-62.0K
↓ 112.42%

Neuronetics Technicals Summary

Sell

Neutral

Buy

Neuronetics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Neuronetics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Neuronetics Inc
29.57%
-18.13%
-46.79%
-65.51%
-64.61%
Idexx Laboratories, Inc.
-7.8%
-13.05%
-23.61%
-25.62%
49.5%
Agilent Technologies Inc.
-5.77%
8.19%
1.73%
-6.52%
55.48%
Thermo Fisher Scientific, Inc.
-0.97%
0.03%
-1.73%
-14.88%
61.41%
Danaher Corp.
-0.45%
-2.06%
-0.01%
-22.5%
48.94%
Iqvia Holdings Inc.
-4.38%
-7.35%
-11.9%
-23.26%
23.76%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Neuronetics Inc
NA
NA
NA
-1.27
-1.0
-0.17
NA
1.18
Idexx Laboratories, Inc.
39.83
39.83
4.35
10.73
0.59
0.23
NA
19.72
Agilent Technologies Inc.
30.63
30.63
2.26
5.56
0.25
0.08
0.01
20.53
Thermo Fisher Scientific, Inc.
32.58
32.58
1.98
21.7
0.13
0.05
0.0
128.08
Danaher Corp.
43.31
43.31
3.07
7.5
0.08
0.04
0.0
71.03
Iqvia Holdings Inc.
25.94
25.94
1.03
11.11
0.22
0.05
NA
38.37
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Neuronetics Inc
Buy
$89.6M
-64.61%
NA
-45.06%
Idexx Laboratories, Inc.
Buy
$33.9B
49.5%
39.83
22.53%
Agilent Technologies Inc.
Buy
$38.8B
55.48%
30.63
21.75%
Thermo Fisher Scientific, Inc.
Buy
$199.0B
61.41%
32.58
14.48%
Danaher Corp.
Buy
$165.8B
48.94%
43.31
16.39%
Iqvia Holdings Inc.
Buy
$35.8B
23.76%
25.94
9.17%

About Neuronetics

with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
Organization
Neuronetics
Employees
203
CEO
Mr. Keith J. Sullivan
Industry
Health Technology

Management People of Neuronetics

NameTitle
Mr. Keith J. Sullivan
President, CEO & Director
Mr. Stephen J. Furlong M.S.
Executive VP, CFO & Treasurer
Mr. Rusty Page
Senior VP of Operations & Quality
Ms. Lisa Metzner-Rosas
Senior VP & Chief Marketing Officer
Ms. Sara Grubbs
Senior VP & Chief Revenue Officer
Mr. Rick Grubbs
Senior Vice President of National Accounts
Mr. Cory S. Anderson
Senior Vice President of R&D and Clinical

Important FAQs about investing in Neuronetics from India :

What is Neuronetics share price today?

Neuronetics share price today stands at $1.57, Open: $1.49 ; Previous Close: $1.49 ; High: $1.58 ; Low: $1.49 ; 52 Week High: $5.07 ; 52 Week Low: $0.52. The stock opens at $1.49, after a previous close of $1.49. The stock reached a daily high of $1.58 and a low of $1.49, with a 52-week high of $5.07 and a 52-week low of $0.52.

Can Indians buy Neuronetics shares?

Yes, Indians can invest in the Neuronetics (STIM) from India.

With INDmoney, you can buy Neuronetics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Neuronetics at zero transaction cost.

How can I buy Neuronetics shares from India?

It is very easy to buy Neuronetics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neuronetics be purchased?

Yes, you can buy fractional shares of Neuronetics with INDmoney app.

What are the documents required to start investing in Neuronetics stocks?

To start investing in Neuronetics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Neuronetics

Today’s highest price of Neuronetics (STIM) is $1.58.

Today’s lowest price of Neuronetics (STIM) is $1.49.

What is today's market capitalisation of Neuronetics

Today's market capitalisation of Neuronetics STIM is 89.6M

What is the 52 Week High and Low Range of Neuronetics

  • 52 Week High

    $5.07

  • 52 Week Low

    $0.52

What are the historical returns of Neuronetics?

  • 1 Month Returns

    29.57%

  • 3 Months Returns

    -18.13%

  • 1 Year Returns

    -46.79%

  • 5 Years Returns

    -64.61%

Who is the Chief Executive Officer (CEO) of Neuronetics

Mr. Keith J. Sullivan is the current Chief Executive Officer (CEO) of Neuronetics.